Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 18 (2), 135-40

Ace Inhibitor Therapy for Heart Failure in Patients With Impaired Renal Function: A Review of the Literature

Affiliations
Review

Ace Inhibitor Therapy for Heart Failure in Patients With Impaired Renal Function: A Review of the Literature

Ali A Valika et al. Heart Fail Rev.

Abstract

Heart failure syndromes are often associated with multi-organ dysfunction, and concomitant liver, renal, and neurologic involvement is very common. Neuro-hormonal antagonism plays a key role in the management of this syndrome, and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are one of the cornerstones of therapy. Cardiorenal physiology is becoming more recognized in these patients with advanced heart failure, and the role of neuro-hormonal blockade in this setting is vaguely defined in the literature. Often, angiotensin-converting enzyme inhibitors are decreased or even withheld in these circumstances. The purpose of this article is to review the role and pathophysiology of ace inhibition and angiotensin receptor blockade in patients with acute and chronic heart failure syndromes and concomitant cardiorenal physiology.

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

References

    1. Kidney Int. 2006 Oct;70(7):1318-24 - PubMed
    1. Eur Heart J. 2011 Oct;32(20):2563-72 - PubMed
    1. Eur Heart J. 1999 Jan;20(2):136-9 - PubMed
    1. Am J Cardiol. 2005 Dec 1;96(11):1530-6 - PubMed
    1. N Engl J Med. 1994 Mar 31;330(13):877-84 - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback